Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yostra Labs is a private Indian medtech company focused on diagnosis and management of diabetic foot complications. The company develops and sells ISO 13485-certified medical devices for peripheral neuropathy assessment, vascular and plantar-pressure screening, and advanced wound care, with flagship products including NEURO TOUCH and VELOX Care. Its solutions are aimed at clinicians, hospitals, diabetic foot centers, and cost-sensitive healthcare markets, especially in India. Yostra positions itself as a healthcare technology company combining portable hardware, cloud-connected reporting, and clinically validated workflows to improve early detection of diabetic foot risk and healing of chronic wounds. The business appears to be commercial-stage rather than a therapeutic drug developer, with revenue-generating products already on the market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yostra Labs.